A case of minimal change nephrotic syndrome with immunoglobulin A nephropathy transitioned to focal segmental glomerulosclerosis

被引:0
作者
Misaki Hirose
Tomoya Nishino
Tadashi Uramatsu
Yoko Obata
Mineaki Kitamura
Tayo Kawazu
Masanobu Miyazaki
Takashi Taguchi
Shigeru Kohno
机构
[1] Nagasaki University School of Medicine,Second Department of Internal Medicine
[2] Nagasaki University Hospital,Division of Blood Purification
[3] Nagasaki University Hospital,Medical Education Development Center
[4] Miyazaki Clinic,Department of Pathology
[5] Nagasaki University Graduate School of Biomedical Sciences,undefined
来源
Clinical and Experimental Nephrology | 2012年 / 16卷
关键词
IgA nephropathy; Minimal change nephrotic syndrome; Mesangial IgA deposition; Focal segmental glomerulosclerosis; Nephrotic syndrome; Influenza virus vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
A 50-year-old woman with a 1-month history of lower extremity edema and a 5 kg weight increase was admitted to our hospital with suspected nephrotic syndrome in October 1999. Urine protein level was 3.5 g per day, 10−15 erythrocytes in urine per high-power field, and serum albumin level 2.5 g/dl. Furthermore, an accumulation of pleural effusion was confirmed by chest X-ray. The results of a renal biopsy indicated slight mesangial proliferation in the glomeruli by light microscopy, and an immunofluorescence study confirmed the deposition of immunoglobulin (Ig) A and C3 in the mesangial area. Diffuse attenuation of foot processes and dense deposits in the mesangial area were observed by electron microscopy. Treatment with 40 mg/day of prednisolone was effective, and proteinuria was negative 1 month later. Because of this course, we diagnosed minimal change nephrotic syndrome complicated by mild-proliferative IgA nephropathy. In November 2000, there was a relapse of nephrotic syndrome, which was believed to be induced by an influenza vaccination, but response to increased steroid treatment was favorable, and proteinuria disappeared on day 13 of steroid increase. A second relapse in May 2001, showed steroid resistance with renal insufficiency, and an increase in the selectivity index to 0.195. Light microscopy revealed focal sclerotic lesions of the glomeruli, and an immunofluorescence study revealed attenuation of mesangial IgA and C3 deposition. These findings led to the diagnosis that minimal change nephrotic syndrome had transitioned to focal segmental glomerulosclerosis, whereby mesangial IgA deposition was reduced by immunosuppressive treatment. Subsequently, her renal function gradually worsened to the point of end-stage renal failure by 27 months after the second relapse of nephrotic syndrome.
引用
收藏
页码:473 / 479
页数:6
相关论文
共 50 条
  • [41] Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis
    Perez, Vanessa
    Lopez, Dolores
    Boixadera, Ester
    Ibernon, Meritxell
    Espinal, Anna
    Bonet, Josep
    Romero, Ramon
    [J]. BMC NEPHROLOGY, 2017, 18
  • [42] Significance of C4d expression in minimal change disease and focal segmental glomerulosclerosis
    Son, Min Jeong
    Park, Jeong Hwan
    Kim, Dong Ki
    Joo, Kwon Wook
    Kim, Sung Gwon
    Hwang, Young Hwan
    Moon, Kyung Chul
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (08): : 8215 - 8222
  • [43] Molecular Profiling in IgA Nephropathy and Focal and Segmental Glomerulosclerosis
    Tycova, I.
    Hruba, P.
    Maixnerova, D.
    Girmanova, E.
    Mrazova, P.
    Stranavova, L.
    Zachoval, R.
    Merta, M.
    Slatinska, J.
    Kollar, M.
    Honsova, E.
    Tesar, V.
    Viklicky, O.
    [J]. PHYSIOLOGICAL RESEARCH, 2018, 67 (01) : 93 - 105
  • [44] Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study
    Lan, Lan
    Lin, Yuxin
    Yu, Binfeng
    Wang, Yin
    Pan, Hong
    Wang, Huijing
    Lou, Xiaowei
    Lang, Xiabing
    Zhang, Qiankun
    Jin, Lie
    Yang, Yi
    Xiao, Liang
    Chen, Jianghua
    Han, Fei
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2024, 55 (01) : 25 - 36
  • [45] Behcet's syndrome and focal segmental glomerulosclerosis with nephrotic syndrome - successful treatment with etanercept
    Leonard, Deanne
    Cortese, Cherise
    Wadei, Hani M.
    Porter, Ivan E., II
    Aslam, Nabeel
    [J]. CLINICAL NEPHROLOGY, 2018, 89 (05) : 371 - 375
  • [46] Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis
    Siligato, Rossella
    Cernaro, Valeria
    Nardi, Chiara
    De Gregorio, Francesca
    Gembillo, Guido
    Costantino, Giuseppe
    Conti, Giovanni
    Buemi, Michele
    Santoro, Domenico
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (11) : 839 - 879
  • [47] Adriamycin nephropathy: A model of focal segmental glomerulosclerosis
    Lee, Vincent W. S.
    Harris, David C. H.
    [J]. NEPHROLOGY, 2011, 16 (01) : 30 - 38
  • [48] Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis
    Eduardo H. Garin
    Jochen Reiser
    Gabriel Cara-Fuentes
    Changli Wei
    Dany Matar
    Heiman Wang
    Nada Alachkar
    Richard J. Johnson
    [J]. Pediatric Nephrology, 2015, 30 : 469 - 477
  • [49] Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis
    Garin, Eduardo H.
    Reiser, Jochen
    Cara-Fuentes, Gabriel
    Wei, Changli
    Matar, Dany
    Wang, Heiman
    Alachkar, Nada
    Johnson, Richard J.
    [J]. PEDIATRIC NEPHROLOGY, 2015, 30 (03) : 469 - 477
  • [50] Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis
    Yabu, J. M.
    Ho, B.
    Scandling, J. D.
    Vincenti, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (01) : 222 - 227